“Destiny:
The product is intended for dietary management in:
• inflammatory diseases of the intestinal mucosa (including ulcerative colitis and Crohn’s disease), intestinal infections and intestinal flora disorders (e.g. after antibiotic therapy);
• intestinal inflammation after radiotherapy and chemotherapy;
• constipation, diarrhea, dyspepsia;
• intestinal disorders (e.g. irritable bowel syndrome);
• nutritional deficiencies (insufficient fiber supply, low-residue diet).
Combining treatment with dietary modification in patients with various gastroenterological diseases may have a beneficial effect on the patients’ quality of life and the severity of symptoms. Butyric acid belongs to the group of short-chain fatty acids and is the basic energy material for the intestinal epithelium. It is produced in physiological conditions, in the process of fiber fermentation in the large intestine. To function properly, the epithelium of the large intestine must be properly nourished, because only then it protects against the entry of bacteria and toxins into the human body from the intestinal content.
Rebutestin forte contains sodium butyrate enclosed in pellets covered with a shell and additionally in a hydroxypropyl methylcellulose capsule. This protects sodium butyrate against the harmful effects of stomach acid and allows it to be transported to the large intestine.”
